New data shows widespread undetected metabolic risk – even among “healthy” individuals – as Noom enables members to test, ...

Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into ...

According to Mochi Health, more than half of its patients lose at least 10% of their body weight within the first six months, ...

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 receptor agonists like semaglutide and tirzepatide. Now, a phase 2 clinical ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Hims & Hers Health ...